Test Price
2,800 AEDโ Home Collection Available
SCN9A Gene Neuropathy (HSAN2) Genetic Test in UAE | 2800 AED | DHA-Approved NGS
Executive Summary & Core Metrics
99.9% Diagnostic Sensitivity โ ISO 9001:2015 accredited processing with Next-Generation Sequencing (NGS) and orthogonal confirmation of pathogenic variants.
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection โ Available daily from 8 AM to 11 PM; sample stability guaranteed for whole blood, extracted DNA, or dried blood spots (FTA Cards).
Complimentary Post-Test Genetic Counselling โ Telephonic result interpretation by a DHA-licensed Consultant Medical Geneticist, ensuring clinical correlation with symptoms and family history.
Direct Billing & Insurance โ WhatsApp verification for all major UAE insurers at +971 54 548 8731 before sample collection.
Test Overview & Methodology
The SCN9A NGS panel screens for pathogenic variants in the SCN9A gene linked to Hereditary Sensory and Autonomic Neuropathy Type 2 (HSAN2), a rare neurological disorder characterised by profound sensory loss and autonomic dysfunction. This test is ordered by Neurologists, Clinical Geneticists, and Pain Management Consultants to confirm a molecular diagnosis, guide prognosis, and enable targeted family screening.
| Feature | Our Test (NGS Panel) | Closest Alternative (Single-Gene Sanger) |
|---|---|---|
| Methodology | Next-Generation Sequencing (NGS) with full coding region coverage ยฑ10 bp, deletions/duplications detected via MLPA | Bidirectional Sanger sequencing of exons only |
| Diagnostic Yield | 99.9% analytical sensitivity; >95% clinical sensitivity for HSAN2 | ~85% for point mutations, misses large rearrangements |
| Turnaround Time | 3โ4 Weeks (expedited reporting available) | 6โ8 Weeks |
Physician Insight & Safety Protocols
โAs a Consultant Medical Genetics specialist, I confirm that SCN9A sequencing is a critical diagnostic tool for HSAN2. However, a positive result must be correlated with clinical phenotype, nerve conduction studies, and autonomic testing. Early molecular confirmation empowers families with reproductive options and tailored pain management strategies. Discuss all results with your treating neurologist before making any therapeutic decisions.โ
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
โ Medication Safety Warning
Do not discontinue or alter any prescribed medication without consulting your supervising physician. This test provides genetic information relevant to HSAN2 and does not replace ongoing neurological care or acute pain management protocols.
Exclusion Criteria & ER Red Flags
- Test cannot be performed on samples contaminated with heparin (green-top tubes) or clotted/cell-free samples.
- Patients under 18 years must have written consent from a legal guardian as per Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- If the patient is currently experiencing autonomic crisis, sepsis, or unsteady vital signs, defer sample collection and seek immediate emergency care.
Patient FAQ & Clinical Guidance
1. What does the SCN9A genetic test diagnose?
This NGS-based test identifies disease-causing variants in the SCN9A gene to confirm Hereditary Sensory and Autonomic Neuropathy Type 2 (HSAN2), a condition that causes loss of pain sensation, temperature insensitivity, and autonomic instability.
2. How long does the result take and what is the cost?
The standard turnaround time is 3 to 4 weeks, and the price is 2800 AED, inclusive of pre-test genetic counselling, sample collection, laboratory analysis, and a comprehensive medical report with ICD-10 and LOINC codes for insurance submission.
3. Is home sample collection available and safe for this?
Yes, we provide ISO 9001:2015 certified home collection with temperature-controlled cold-chain transport; a trained phlebotomist arrives at your doorstep between 8 AM and 11 PM, ensuring sample integrity for whole blood, extracted DNA, or FTA cards without compromising diagnostic accuracy.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is stored encrypted, accessed only by authorized personnel, and never shared without explicit patient consent. For complaints or data access requests, contact our Data Protection Officer at dpo@dnalabsuae.com.
Clinical & Logistical Metadata
| Test Name | SCN9A Gene Neuropathy (HSAN2) Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3โ4 weeks (expedited reporting available) |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or Dried Blood Spots (FTA Cards) |
| Methodology Used | Next-Generation Sequencing (NGS) with MLPA for deletion/duplication detection |
| ICD-10-CM Code | G60.8 |
| LOINC Code | 82939-0 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 ยท DNA Labs UAE ยท Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians